Trinity Biotech (TRIB) Short-term Investments (2017 - 2025)

Trinity Biotech has disclosed Short-term Investments across 6 years of filings, most recently posting $67000.0 for Q2 2025.

• Short-term Investments for Q2 2025 came in at $67000.0, down 65.28% year-over-year; the trailing twelve-month figure through Jun 2025 was $67000.0 (down 65.28% YoY), and the FY2024 annual result was $166000.0, down 6.74% from the prior year.
• Short-term Investments came in at $67000.0 for Q2 2025 at Trinity Biotech, down from $166000.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $232000.0 in Q1 2024 to a low of $67000.0 in Q2 2025.
• The 4-year median for Short-term Investments is $178000.0 (2023), against an average of $170923.1.
• Across the five-year window, Short-term Investments jumped 52.86% in 2023 and sank 65.28% in 2025, its largest moves.
• Trinity Biotech's Short-term Investments stood at $128000.0 in 2022, then surged by 39.06% to $178000.0 in 2023, then declined by 6.74% to $166000.0 in 2024, then tumbled by 59.64% to $67000.0 in 2025.
• The last three Short-term Investments figures came in at $67000.0 (Q2 2025), $166000.0 (Q4 2024), and $190000.0 (Q3 2024), per Business Quant data.